Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 539 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 1-25 of 539 matching filings.

Per page
25
Current page
1
4/A

4/A filing

Filing date
28 Aug 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
28 Aug 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-90232

SCHEDULE 13D filing

Filing date
21 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-298266

EFFECT filing

Filing date
20 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Aug 2026
Reporting date
13 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Aug 2026
Reporting date
13 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Aug 2026
Reporting date
12 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38327

144 filing

Filing date
14 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90232

SCHEDULE 13G filing

Filing date
14 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38327

144 filing

Filing date
13 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Aug 2026
Reporting date
30 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Aug 2026
Reporting date
30 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
30 Jul 2026
Reporting date
01 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-591745

D filing

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jul 2026
Reporting date
13 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Jul 2026
Reporting date
13 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jul 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jul 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jul 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jul 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jul 2026
Reporting date
09 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .